Immorna Biotherapeutics
Jinan, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A biotech developing next-generation vaccines and therapies using its proprietary circular RNA and delivery technology platform.
Infectious DiseasesOncologyRare Diseases
Technology Platform
Proprietary circular RNA (circRNA) design and manufacturing platform combined with lipid nanoparticle (LNP) delivery technology.
Opportunities
Potential to develop best-in-class RNA therapeutics with longer-lasting effects across multiple high-value disease areas.
Risk Factors
Unproven clinical efficacy and safety of its circRNA platform, alongside the technical and manufacturing complexities of RNA therapies.
Competitive Landscape
Competes in the fast-evolving RNA therapeutics arena against established mRNA leaders and other circRNA startups.